ARCHIVES

Expert Review Of ImClone Protocol Concludes C225 Approval Unlikely.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Long-Term Remissions Shown With Chemo Plus Radiation

September 29, 2006

How the Institute Fared In House Markup: Chart

July 18, 1997

UCSF. Roswell Park Win National Cooperative Drug Discovery Group Awards; RFA To Be Reissued

June 15, 1984

New Test Predicts Breast Cancer Recurrence And Who Benefits Most From Chemotherapy

December 31, 2004

As Avastin Decision Nears, Patient Groups Split On PFS In Front Line Breast Cancer.

February 22, 2008

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

July 4, 2003